Carla Washington

1.1k total citations
31 papers, 896 citations indexed

About

Carla Washington is a scholar working on Genetics, Hematology and Infectious Diseases. According to data from OpenAlex, Carla Washington has authored 31 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Genetics, 8 papers in Hematology and 6 papers in Infectious Diseases. Recurrent topics in Carla Washington's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and HIV/AIDS drug development and treatment (6 papers). Carla Washington is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (8 papers) and HIV/AIDS drug development and treatment (6 papers). Carla Washington collaborates with scholars based in United States, Switzerland and Lebanon. Carla Washington's co-authors include Kathleen M. Giacomini, Ludger Banken, René Bruno, Jianfeng Lü, Pamela Klein, Grazyna Liebérman, Terrence F. Blaschke, George E. Durán, Branimir I. Šikić and Sheng‐Fang Su and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Hepatology.

In The Last Decade

Carla Washington

30 papers receiving 857 citations

Peers

Carla Washington

ONCOL

GENET

EPIDE

Shaun Loewen Canada

Sarah Allegra Italy

Kentaro Watanabe Japan

Lewis M. Slater United States

James W. Darnowski United States

Kenneth A. West Canada

Mukul Minocha United States

Hung-Liang Tai United States

Xinglin Wu United States

Caly Chien United States

Shaun Loewen Canada

Carla Washington

271 ×1.0

ONCOL

111 ×0.5

195 ×1.1

68 ×0.4

GENET

83 ×0.5

EPIDE

Citations per year, relative to Carla Washington Carla Washington (= 1×) peers Shaun Loewen

Countries citing papers authored by Carla Washington

Since Specialization

Citations

This map shows the geographic impact of Carla Washington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Washington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Washington more than expected).

Fields of papers citing papers by Carla Washington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Washington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Washington. The network helps show where Carla Washington may publish in the future.

Co-authorship network of co-authors of Carla Washington

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Washington. A scholar is included among the top collaborators of Carla Washington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Washington. Carla Washington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lisbon, Eleanor, R. Clark Brown, Andrew Redfern, et al.. (2025). Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First‐in‐Human Studies in Healthy Participants and Patients. Clinical Pharmacology & Therapeutics. 119(1). 120–130.

Estepp, Jeremie H., Ram Kalpatthi, Gerald M. Woods, et al.. (2022). Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years. Pediatric Blood & Cancer. 69(8). e29716–e29716. 31 indexed citations

Green, Michelle, et al.. (2022). Model‐informed drug development of voxelotor in sickle cell disease: Exposure‐response analysis to support dosing and confirm mechanism of action. CPT Pharmacometrics & Systems Pharmacology. 11(6). 698–710. 4 indexed citations

Brown, R. Clark, Andrew Redfern, Eleanor Lisbon, et al.. (2021). GBT021601, a Next Generation HbS Polymerization Inhibitor: Results of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Adults Living with Sickle Cell Disease and Healthy Volunteers. Blood. 138(Supplement 1). 3099–3099. 5 indexed citations

Brown, R. Clark, Carolyn Hoppe, Adlette Inati, et al.. (2018). Efficacy and Safety of 1500 mg Voxelotor in a Phase 2a Study (GBT440-007) in Adolescents with Sickle Cell Disease. Blood. 132(Supplement 1). 509–509. 4 indexed citations

Washington, Carla, et al.. (2013). Single-dose Pharmacokinetics of the HCV Polymerase Inhibitor Mericitabine in Healthy Caucasian and Japanese Subjects. Drug Metabolism and Pharmacokinetics. 29(2). 141–147. 5 indexed citations

Welker, Horst A., Mahdi Farhan, Atul Humar, & Carla Washington. (2010). Ganciclovir Pharmacokinetic Parameters Do Not Change When Extending Valganciclovir Cytomegalovirus Prophylaxis From 100 to 200 Days. Transplantation. 90(12). 1414–1419. 22 indexed citations

Roberts, Stuart K., Graham Cooksley, Gregory J. Dore, et al.. (2008). Robust antiviral activity of R1626, a novel nucleoside analog. Hepatology. 48(2). 398–406. 87 indexed citations

Brandl, Michael, Xiaoyang Wu, Hong Lei, et al.. (2008). Physicochemical Properties of the Nucleoside Prodrug R1626 Leading to High Oral Bioavailability. Drug Development and Industrial Pharmacy. 34(7). 683–691. 29 indexed citations

10.

Washington, Carla, et al.. (2007). Ciprofloxacin Prolonged‐Release Tablets Do Not Affect Warfarin Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology. 47(10). 1320–1326. 12 indexed citations

11.

Washington, Carla, et al.. (2005). Pharmacokinetics and Pharmacodynamics of a Novel Extended‐Release Ciprofloxacin in Healthy Volunteers. The Journal of Clinical Pharmacology. 45(11). 1236–1244. 7 indexed citations

12.

Bruno, René, Carla Washington, Jianfeng Lü, et al.. (2005). Population pharmacokinetics of trastuzumab in patients With HER2+ metastatic breast cancer. Cancer Chemotherapy and Pharmacology. 56(4). 361–369. 202 indexed citations

13.

Washington, Carla, Charles Flexner, Lewis B. Sheiner, et al.. (2003). Effect of simultaneous versus staggered dosing on pharmacokinetic interactions of protease inhibitors. Clinical Pharmacology & Therapeutics. 73(5). 406–416. 16 indexed citations

14.

Washington, Carla, et al.. (1998). Interaction of Anti-HIV Protease Inhibitors With the Multidrug Transporter P-Glycoprotein (P-gp) in Human Cultured Cells. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 19(3). 203–209. 124 indexed citations

15.

Washington, Carla, et al.. (1998). Nucleoside Transport in Isolated Human and Rhesus Choroid Plexus Tissue Slices. Pharmaceutical Research. 15(7). 1145–1147. 7 indexed citations

16.

Washington, Carla, Kathleen M. Giacomini, & Claire M. Brett. (1996). Methods to Study Drug Transport in Isolated Choroid Plexus Tissue and Cultured Cells. Pharmaceutical biotechnology. 8. 259–283. 3 indexed citations

17.

Washington, Carla & Kathleen M. Giacomini. (1996). Mechanisms of 5-Fluorouracil (5-FU) Transport in Isolated Rabbit Choroid Plexus Tissue Slices. Pharmaceutical Research. 13(8). 1276–1278. 5 indexed citations

18.

Washington, Carla & Kathleen M. Giacomini. (1995). Mechanisms of Nucleobase Transport in Rabbit Choroid Plexus. Journal of Biological Chemistry. 270(39). 22816–22819. 32 indexed citations

19.

Washington, Carla, et al.. (1993). Interaction of Nucleoside Analogues with the Sodium–Nucleoside Transport System in Brush Border Membrane Vesicles from Human Kidney. Pharmaceutical Research. 10(3). 423–426. 63 indexed citations

20.

Washington, Carla, et al.. (1990). Cardiovascular effects of doxorubicin. General Pharmacology The Vascular System. 21(5). 729–733. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact